Jacques Touchon

10.4k total citations · 1 hit paper
100 papers, 5.0k citations indexed

About

Jacques Touchon is a scholar working on Psychiatry and Mental health, Physiology and Cognitive Neuroscience. According to data from OpenAlex, Jacques Touchon has authored 100 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Psychiatry and Mental health, 33 papers in Physiology and 20 papers in Cognitive Neuroscience. Recurrent topics in Jacques Touchon's work include Dementia and Cognitive Impairment Research (51 papers), Alzheimer's disease research and treatments (32 papers) and Neurological Disease Mechanisms and Treatments (13 papers). Jacques Touchon is often cited by papers focused on Dementia and Cognitive Impairment Research (51 papers), Alzheimer's disease research and treatments (32 papers) and Neurological Disease Mechanisms and Treatments (13 papers). Jacques Touchon collaborates with scholars based in France, United States and United Kingdom. Jacques Touchon's co-authors include Karen Ritchie, Sylvaine Artéro, Florence Portet, Marie‐Laure Ancelin, Yves Dauvilliers, Anne‐Marie Dupuy, A Besset, Bernard Ledésert, Serge Gauthier and Audrey Gabelle and has published in prestigious journals such as The Lancet, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Jacques Touchon

98 papers receiving 4.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Classification criteria for mild cognitive impairment

2001 675 citations Karen Ritchie, Sylvaine Artéro et al. profile →

Peers

Countries citing papers authored by Jacques Touchon

Since Specialization

Citations

This map shows the geographic impact of Jacques Touchon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques Touchon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques Touchon more than expected).

Fields of papers citing papers by Jacques Touchon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacques Touchon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques Touchon. The network helps show where Jacques Touchon may publish in the future.

Co-authorship network of co-authors of Jacques Touchon

This figure shows the co-authorship network connecting the top 25 collaborators of Jacques Touchon. A scholar is included among the top collaborators of Jacques Touchon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacques Touchon. Jacques Touchon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Brain photobiomodulation: a potential treatment in Alzheimer’s and Parkinson’s diseases 2025 ·The Journal of Prevention of Alzheimer s Disease ·(unknown), (unknown), (unknown), (unknown), Frédéric Pain, Michael Weiner, Marwan N. Sabbagh, Cécile Moro, Jacques Touchon	1
2	Translation from Preclinical Research to Clinical Trials: Brain–Gut Photobiomodulation Therapy for Alzheimer's Disease 2024 ·Journal of Integrative Neuroscience ·(unknown), François J. Roman, Julien Delrieu, Jacques Touchon	3
3	Cumulative effects of subsequent concussions on the neural patterns of young rugby athletes: data from event-related potentials 2023 ·Research in Sports Medicine ·Karim Bennys, Germain U. Busto, Jacques Touchon	2
4	Neuroprotection Afforded by a Preventive CogniXtra Treatment Against Amyloid Beta Aβ25-35 Peptide-induced Toxicity in Mice 2019 ·(unknown), François Roman, Johann Meunier, Laura Ceolin, (unknown), Jacques Touchon	1
5	Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric study 2015 ·Alzheimer s Research & Therapy ·Julien Dumurgier, Susanna Schraen, Audrey Gabelle, Olivier Vercruysse, Stéphanie Bombois, Jean Laplanche, Katell Peoc’h, Bernard Sablonnière, Ksenia V. Kastanenka, Constance Delaby, Florence Pasquier, Jacques Touchon, Jacques Hugon, Claire Paquet, Sylvain Lehmann	108
6	Education Modulates the Impact of White Matter Lesions on the Risk of Mild Cognitive Impairment and Dementia 2013 ·American Journal of Geriatric Psychiatry ·Marion Mortamais, Florence Portet, Adam M. Brickman, Frank A. Provenzano, Jordan Muraskin, Tasnime Akbaraly, Claudine Berr, Jacques Touchon, Alain Bonafé, Emmanuelle Le Bars, Nicolas Menjot de Champfleur, Jerome J. Maller, Chantal Meslin, Robert Sabatier, Karen Ritchie, Sylvaine Artéro	62
7	Long-term use of standardised ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial 2012 ·The Lancet Neurology ·Bruno Vellas, Nicola Coley, Pierre‐Jean Ousset, Gilles Berrut, Jean‐François Dartigues, Bruno Dubois, H. Grandjean, Florence Pasquier, F. Piette, Philippe Robert, Jacques Touchon, Philippe Garnier, Hélène Mathiex‐Fortunet, Sandrine Andrieu	246
8	Correlations between soluble α/β forms of amyloid precursor protein and Aβ38, 40, and 42 in human cerebrospinal fluid 2010 ·Brain Research ·Audrey Gabelle, Stéphane Roche, Christian Gény, Karim Bennys, Pierre Labauge, Yannick Tholance, Isabelle Quadrio, Laurent Tiers, (unknown), (unknown), Alain Vighetto, Bernard Croisile, Pierre Krolak‐Salmon, Jacques Touchon, Armand Perret‐Liaudet, Sylvain Lehmann	54
9	Metabolic Syndrome, Its Components, and Mortality in the Elderly 2010 ·The Journal of Clinical Endocrinology & Metabolism ·Tasnime Akbaraly, Mika Kivimäki, Marie‐Laure Ancelin, Pascale Barberger‐Gateau, Thibault Mura, Christophe Tzourio, Jacques Touchon, Karen Ritchie, Claudine Berr	27
10	Brain perfusion SPECT with an automated quantitative tool can identify prodromal Alzheimer's disease among patients with mild cognitive impairment 2009 ·Neurobiology of Aging ·Marie‐Odile Habert, (unknown), Marie Sarazin, Jean-Albert Lotterie, Michèle Puel, Fannie Onen, Michel Zanca, Florence Portet, Jacques Touchon, Marc Verny, Florence Mahieux, Alain Giron, Bernard Fertil, Bruno Dubois	58
11	Relevance of the Evaluation Criteria Used in Clinical Trials for Alzheimer’s Disease 2009 ·Therapies ·Philippe Truffinet, Régis Bordet, Joël Ménard, Serge Bakchine, Luc Buée, (unknown), (unknown), Bruno Dubois, Françoise Duveau, Jean‐Marie Goehrs, (unknown), (unknown), (unknown), Jean‐Marc Orgogozo, Florence Pasquier, (unknown), Franck Semah, Jacques Touchon, Marc Verny, Mohammed Zaïm	5
12	Restless legs syndrome in narcolepsy: A side effect of sodium oxybate? 2007 ·Sleep Medicine ·Beatriz Abril, Bertrand Carlander, Jacques Touchon, Yves Dauvilliers	18
13	Mild Cognitive Impairment 2007 ·La Presse Médicale ·Jacques Touchon, Florence Portet	4
14	O1–05–06: Free and Cued Recall Test in memory clinics: A good predictor of conversion to AD or a marker of prodromal AD ? 2006 ·Alzheimer s & Dementia ·Claudine Berr, Marie Sarazin, Colette Fabrigoule, B. Michel, Jocelyne de Rotrou, Michèle Puel, Marc Verny, Sylvie Legrain, Jacques Touchon, Bruno Dubois, (unknown)	1
15	Effect of age on response to rivastigmine or donepezil in patients with Alzheimer's disease 2006 ·Current Medical Research and Opinion ·Roger Bullock, Howard Bergman, Jacques Touchon, Giuseppe Gambina, Yunsheng He, (unknown), Roger Lane	47
16	Revised Criteria for Mild Cognitive Impairment: Validation within a Longitudinal Population Study 2006 ·Dementia and Geriatric Cognitive Disorders ·Sylvaine Artéro, Ronald Petersen, Jacques Touchon, Karen Ritchie	173
17	Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study 2006 ·BMJ ·Marie‐Laure Ancelin, Sylvaine Artéro, Florence Portet, Anne‐Marie Dupuy, Jacques Touchon, Karen Ritchie	440
18	Does Education Level Determine the Course of Cognitive Decline? 1996 ·Age and Ageing ·Didier Leibovici, Karen Ritchie, Bernard Ledésert, Jacques Touchon	58
19	A Typology of Sub-Clinical Senescent Cognitive Disorder 1996 ·The British Journal of Psychiatry ·Karen Ritchie, Didier Leibovici, Bernard Ledésert, Jacques Touchon	56
20	Heterogeneity in senile dementia of the Alzheimer type: Individual differences, progressive deterioration or clinical sub-types? 1992 ·Journal of Clinical Epidemiology ·Karen Ritchie, Jacques Touchon	52

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact